ITGB8 and inflammatory bowel disease: For example, in benign diseases, intestinal antigen-presenting cells can promote regulatory T cell activity via ITGB8, resulting in immune tolerance in the intestine to alleviate inflammatory bowel disease (Akagbosu et al. 2022).